LIPOPOLYSACCHARIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF FETAL MALFORMATIONS

The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congeni...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LLAMAS MATÍAS, Miguel Angel, VALLEJO CREMADES, María Teresa, FRESNO ESCUDERO, Manuel
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention refers to lipopolysaccharides, characterized in that they are agonist of both Toll-like Receptors TLR2 and TLR4, for use in the prevention and/or treatment of fetal malformations, preferably fetal malformations caused by malformations of muscle connective tissue such as Congenital diaphragmatic hernia (CDH).